Beta-Blockers Show Promise in Curbing HD Progression

TOPLINE: Beta-blocker use is associated with a 34% reduction of onset in premanifest Huntington disease (preHD) and slower progression in early motor-manifest Huntington disease (mmHD), new research shows.  METHODOLOGY: In this longitudinal multicenter study, 174 beta-blocker users with preHD (mean age, 46.4 years; 66% women) were matched with 174 nonusers (mean age, 48 years; 66% … Read more

Doxycycline Kits Boost Chlamydia Treatment in ED

TOPLINE: Doxycycline discharge kits significantly improve guideline-directed treatment and reduce time to definitive treatment in patients with chlamydia who were discharged from the emergency department (ED). METHODOLOGY: A single-center retrospective chart review included adults with positive chlamydia tests in the ED between 2021 and 2023. In total, 98 received doxycycline discharge kits; 72 patients were … Read more

AI Detects Epileptic Lesions Missed by MRI

Can AI unmask Hidden Epilepsy Lesions? Table of Contents Can AI unmask Hidden Epilepsy Lesions? AI Algorithm Shows Promise in Detecting Hidden Epilepsy Lesions AI Could Revolutionize Epilepsy Diagnosis and Treatment Can AI Unmask Hidden Epilepsy Lesions? New AI Algorithm Shows Promise in Detecting Subtle Brain Abnormalities How the AI Algorithm Works Open-Source and Collaborative … Read more

Almost All Leading Large Language Models Show Signs of Mild Cognitive Impairment: Study

With the exception of ChatGPT 4o, almost all publicly available large language models subjected to a test called the Montreal Cognitive Assessment (MoCA) showed signs of mild cognitive impairment. These findings challenge the assumption that artificial intelligence will soon replace human doctors, as the cognitive impairment evident in leading chatbots may affect their reliability in … Read more